Playback speed
10 seconds
Effect of Neutralizing Monoclonal Antibody Treatment on Virologic and Immunologic Biomarkers in Patients With COVID-19, SARS-CoV-2 Virologic Rebound With Nirmatrelvir–Ritonavir Therapy, and Optimization of Antiviral Therapy in Immunocompromised COVID-19 Patients
92 views
November 27, 2023
Login to view comments.
Click here to Login